Todd Bull

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Centre, United States of America

Todd Bull is Associate Professor of Medicine in the Division of Pulmonary Sciences and Critical Care Medicine at University of Colorado Health Sciences Center. He is Medical Director of the Anshutz Intensive Care Unit there. He is also Clinical Instructor at the University Hospital.

His research is focused on the mechanisms of the development of pulmonary hypertension and the treatment of this disease. He in involved in both basic scientific and clinical research trials.

Professor Bull is a Member of the American Thoracic Society and the Pulmonary Hypertension Association. He is a Member of the Scientific Leadership Council of the PHA and is on the Editorial Board of Advances in Pulmonary Hypertension, the official journal of the Pulmonary Hypertension Association. He has been recipient of the Mark Flapan Award for Scleroderma Research.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Respiratory Disorders > Pulmonary Vascular Diseases (since 01 June 2007)

All recent recommendations

• 3.0
  Growth Differentiation Factor-15 in Idiopathic Pulmonary Arterial Hypertension.
  Recommended by Todd Bull with Michael Risbano
  
• 6.0
  Clinical Outcomes of Pulmonary Arterial Hypertension in Carriers of BMPR2 Mutation.
  Recommended by Todd Bull with Michael G Risbano
  
• 3.0
  Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients.
  Recommended by Todd Bull
  
• 4.8
  Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.
  Recommended by Luke Howard, Todd Bull
  
• 3.2
  A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology.
  Recommended by Todd Bull, Ronald Oudiz